Abstract
Background: We present a case of a patient with the sequential development of clinical symptoms characteristic of multiple sclerosis, polymyositis, and malignant melanoma. Case presentation: Polymyositis occurred two years after the onset of multiple sclerosis. Clinical signs of melanoma were identified following the development of polymyositis. Treatment with corticosteroids and immunosuppressants positively affected the patient’s clinical manifestations of multiple sclerosis. It remains unclear whether there was an insidious progression of melanoma without clinical manifestations and whether the myositis developed in parallel with this melanoma. It is possible that polymyositis developed independently or preceded the onset of melanoma with lymph node metastases. Conclusion: The patient's clinical history demonstrates an overlap of demyelinating, systemic, and malignant diseases. Integrated treatment is essential for achieving clinical improvement in these patients.
References
1. Lublin FD, Reingold SC: Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996 Apr; 46(4):907-11.
2. Casetta I, Iuliano G, Filippini G. Azathioprine for multiple sclerosis. Cochrane Database of Systematic Reviews 2007, Issue 4.
3. Luo R, Xia D, Siyang Yu Z. A meta-analysis of melanoma risk in idiopathic inflammatory myopathy patients Rheumatol 2024 https://doi.org/10.1007/s00393-024-01473-3
4. Sigurgeirsson B, Lindelof B, Edhag O, et al. Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. N Engl J Med 1992; 326: 363–7.
5. Polymyositis occurring during α-interferon treatment for malignant melanoma: a case report and review of the literature G. Cirigliano, A. Della Rossa, A. Tavoni, P. Viacava & S. Bombardieri Rheumatology International volume 19, pages65–67 (1999)
6. Melamed Е, William Lee M. Multiple Sclerosis and Neuroimmunology Front. Immunol. Volume 10 (2019)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Valentina Reshkova (Author)
